跳至主要内容
临床试验/NL-OMON54302
NL-OMON54302招募中不适用

A randomized controled trial: the effect of a medical grade honey formulation (L-Mesitran®) on clinical symptoms of recurrent vulvovaginal candidiasis - The Honey Study

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 252 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
252

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • Women of at least 18 years old
  • Recurrent vulvovaginal candidiasis (At least 3 episodes of clinical symptoms
  • during the last year)
  • Clinical and microbiological diagnosis of (recurrent) vulvovaginal
  • candidiasis at time of consultation
  • Capacity to understand, consent, and comply with the trial procedures

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Mixed vaginal infections
  • Pregnancy or the intention to become pregnant during the study period
  • Women using systemic or topical antifungal medication during the last two
  • weeks prior to inclusion
  • Known allergies or containdications for Fluconazole or honey
  • Candida with resistance for Fluconazole
  • Women giving breastfeeding

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验